200 mg T25 (Atazanavir Sulfate 200 mg)
Pill with imprint 200 mg T25 is Blue, Capsule-shape and has been identified as Atazanavir Sulfate 200 mg. It is supplied by Aurobindo Pharma Limited.
Atazanavir is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Atazanavir 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 200 mg T25
Atazanavir Sulfate
- Imprint
- 200 mg T25
- Strength
- 200 mg
- Color
- Blue
- Size
- 21.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma Limited
- National Drug Code (NDC)
- 65862-0712
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
FD&C Blue No. 2,
ferrosoferric oxide,
ferric oxide red,
ferric oxide yellow,
titanium dioxide,
potassium hydroxide,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
More about atazanavir
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: protease inhibitors
- FDA Alerts (2)
Consumer resources
- Patient Information
- Atazanavir (Advanced Reading)
- Atazanavir Capsules
- Atazanavir Powder for Oral Suspension
- Other brands
- Reyataz
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.